102 related articles for article (PubMed ID: 18589288)
1. [Anemia and lung cancer].
Bréchot JM; Morère JF
Rev Pneumol Clin; 2008 Apr; 64(2):81-4. PubMed ID: 18589288
[TBL] [Abstract][Full Text] [Related]
2. September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents.
Aapro MS; Link H
Oncologist; 2008; 13 Suppl 3():33-6. PubMed ID: 18458123
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin and chronic lymphocytic leukemia.
Mauro FR; Gentile M; Foa R
Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
[TBL] [Abstract][Full Text] [Related]
4. Epoetin beta once weekly: review of its efficacy and safety in patients with chemotherapy-induced anemia.
Spaëth D
Expert Rev Anticancer Ther; 2008 Jun; 8(6):875-85. PubMed ID: 18533797
[TBL] [Abstract][Full Text] [Related]
5. Weekly administration of epoetin beta for chemotherapy-induced anemia in cancer patients: results of a multicenter, Phase III, randomized, double-blind, placebo-controlled study.
Tsuboi M; Ezaki K; Tobinai K; Ohashi Y; Saijo N
Jpn J Clin Oncol; 2009 Mar; 39(3):163-8. PubMed ID: 19164318
[TBL] [Abstract][Full Text] [Related]
6. EPO in cancer anemia: benefits and potential risks.
Milano M; Schneider M
Crit Rev Oncol Hematol; 2007 May; 62(2):119-25. PubMed ID: 17197190
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
Nowrousian MR
Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
[TBL] [Abstract][Full Text] [Related]
8. Once-weekly epoetin beta (30,000 IU) in anemic patients with lung cancer receiving chemotherapy.
Pirker R; Lehnert M; Minar W
Lung Cancer; 2007 Jan; 55(1):89-94. PubMed ID: 17084484
[TBL] [Abstract][Full Text] [Related]
9. [Tumor anemia. Overview of the role of human recombinant erythropoietin (r-hu-EPO) in treatment of tumor anemia].
Monnerat C; Leyvraz S
Praxis (Bern 1994); 1999 Jan; 88(5):178-88. PubMed ID: 10067375
[TBL] [Abstract][Full Text] [Related]
10. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
[TBL] [Abstract][Full Text] [Related]
11. Intravenous iron and recombinant human erythropoietin in cancer patients.
Beguin Y
J Clin Oncol; 2005 Jan; 23(3):651-2; author reply 652-3. PubMed ID: 15659518
[No Abstract] [Full Text] [Related]
12. [Anemia in lung cancer patients].
Méric JB; Morère JF;
Bull Cancer; 2005 May; 92(5):439-44. PubMed ID: 15932807
[TBL] [Abstract][Full Text] [Related]
13. Role of epoetin in the management of anaemia in patients with lung cancer.
Morère JF
Lung Cancer; 2004 Nov; 46(2):149-56. PubMed ID: 15474662
[TBL] [Abstract][Full Text] [Related]
14. [Improvement of anemia and quality of life of patients with prostate cancer by treatment with human recombinant erythropoietin].
Queipo Zaragozá JA; Chicote Pérez F; Beltrán Meseguer JF; Borrell Palanca A; Giner Marco V; Esteve Claramunt J; Pastor Sempere F
Arch Esp Urol; 2004; 57(1):35-40. PubMed ID: 15112869
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin has an anti-myeloma effect - a hypothesis based on a clinical observation supported by animal studies.
Mittelman M; Zeidman A; Kanter P; Katz O; Oster H; Rund D; Neumann D
Eur J Haematol; 2004 Mar; 72(3):155-65. PubMed ID: 14962233
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin usage in patients with cancer.
Wood PA; Hrushesky WJ
Cancer J Sci Am; 1995; 1(4):243-6. PubMed ID: 9166482
[No Abstract] [Full Text] [Related]
17. Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
Desai J; Demetri GD
Best Pract Res Clin Haematol; 2005; 18(3):389-406. PubMed ID: 15792913
[TBL] [Abstract][Full Text] [Related]
18. [Predictive response variables to recombinant human erythropoietin treatment in patients with anemia and cancer].
Lastiri JM; Specterman SR; Rendo P; Pallotta MG; Varela MS; Goldstein S
Medicina (B Aires); 2002; 62(1):41-7. PubMed ID: 11965849
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin in cancer: the new face of an old friend.
Megalakaki C
J BUON; 2008; 13(1):7-16. PubMed ID: 18404780
[TBL] [Abstract][Full Text] [Related]
20. [Standards, Options, and Recommendations for using erythropoietin in cancerology].
Spaëth D; Marchal C; Blanc-Vincent MP
Bull Cancer; 1998 Apr; 85(4):337-46. PubMed ID: 9752298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
